LASSBio-753 as a new prototype of anti-tumor necrosis factor-alpha anti-inflammatory drug

Biomedicine & Pharmacotherapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles